GREM1 and neoplasm: Gremlin-1 expression was confirmed in normal, metaplastic, and malignant stomach tissues, where epithelial Gremlin-1 expression was found to be linked with tumor progression and to be an independent predictor of poor survival in gastric cancer (GC) patients.